Resistance to EGFR Tyrosine Kinase Inhibitor Therapy in Non-Small-Cell Lung Cancer via Newly Acquired Targetable Oncogenic Driver Alterations With an Emphasis on BRAF : Case Series and Literature Review of Treatment.
Nicholas P GiustiniSandip Pravin PatelNathaniel J MyallJosé Fernando do Prado MouraAmit A KulkarniRichard C ChaoHeather A WakeleeLyudmila BazhenovaPublished in: JCO precision oncology (2022)